Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18865/ed.30.3.429 http://scihub22266oqcxt.onion/10.18865/ed.30.3.429 32742146!7360182!32742146     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ethn+Dis 2020 ; 30 (3): 429-432 Nephropedia Template TP {{tp|p=32742146|t=2020. Impact of COVID-19 on Clinical Research and Inclusion of Diverse Populations |pdf=|usr=}}{{32742146}} gab.com Text Impact of COVID-19 on Clinical Research and Inclusion of Diverse Populations JO: Ethn Dis http://www.kidney.de/pget.php?&tw=1&pmid=32742146 #FOAvip The randomized clinical trial (RCT) has long been recognized as the 'gold standard' for developing evidence for clinical treatments and vaccines; however, the successful implementation and translation of these findings is predicated upon external validity. The generalization of RCT findings are jeopardized by the lack of participation of at-risk groups such as African Americans, with long-recognized disproportional representation. Distinct factors that deter participation in RCTs include distrust, access, recruitment strategies, perceptions of research, and socioeconomic factors. While strategies have been implemented to improve external validity with greater participation among all segments of the population in RCTs, the coronavirus disease 2019 (COVID-19) pandemic may exacerbate disparities in RCT participation with the potential impact of delaying treatment development and vaccine interventions that are applicable and generalizable. Thus, it is essential to include diverse populations in such strategies and RCTs. This Perspective aims to direct attention to the additional harm from the pandemic as well as a refocus on the unresolved lack of inclusion of diverse populations in conducting RCTs. Twit Text FOAVip Impact of COVID-19 on Clinical Research and Inclusion of Diverse Populations ????Ethn Dis http://www.kidney.de/pget.php?&tw=1&pmid=32742146 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32742146 #FOAvip English Wikipedia <ref>{{Cite pmid|32742146}}</ref> Impact of COVID-19 on Clinical Research and Inclusion of Diverse Populations #MMPMID32742146 Lackland DT; Sims-Robinson C; Jones Buie JN; Voeks JH Ethn Dis 2020[Sum]; 30 (3): 429-432 PMID32742146show ga The randomized clinical trial (RCT) has long been recognized as the 'gold standard' for developing evidence for clinical treatments and vaccines; however, the successful implementation and translation of these findings is predicated upon external validity. The generalization of RCT findings are jeopardized by the lack of participation of at-risk groups such as African Americans, with long-recognized disproportional representation. Distinct factors that deter participation in RCTs include distrust, access, recruitment strategies, perceptions of research, and socioeconomic factors. While strategies have been implemented to improve external validity with greater participation among all segments of the population in RCTs, the coronavirus disease 2019 (COVID-19) pandemic may exacerbate disparities in RCT participation with the potential impact of delaying treatment development and vaccine interventions that are applicable and generalizable. Thus, it is essential to include diverse populations in such strategies and RCTs. This Perspective aims to direct attention to the additional harm from the pandemic as well as a refocus on the unresolved lack of inclusion of diverse populations in conducting RCTs. |*Coronavirus Infections/ethnology/therapy[MESH] |*Pandemics[MESH] |*Patient Selection[MESH] |*Pneumonia, Viral/ethnology/therapy[MESH] |*Randomized Controlled Trials as Topic/methods/standards[MESH] |Betacoronavirus[MESH] |Black or African American[MESH] |COVID-19[MESH] |Health Status Disparities[MESH] |Humans[MESH] |Male[MESH] |Patient Participation[MESH] |SARS-CoV-2[MESH] |Socioeconomic Factors[MESH]Impact of COVID-19 on Clinical Research and Inclusion of Diverse Popul(epmc).pdf DeepDyve Pubget Overpricing